Status:
RECRUITING
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Sexual Dysfunction
Stem Cell Transplant Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem ...
Detailed Description
Autologous and Allogeneic hematopoietic stem cell transplant (HCT) are potentially curative treatments for many patients with hematologic malignancies and benign hematologic conditions. The use of HCT...
Eligibility Criteria
Inclusion
- Adult patients (\> 18 years) who underwent autologous or allogeneic HCT \> three months prior to study enrollment
- Screen positive for sexual health concerns causing distress based on the National Comprehensive Network (NCCN) survivorship guidelines screening questions
Exclusion
- Patients who do not comprehend English or Spanish since SHIFT will only be available in these two languages for this efficacy trial.
- Patients with any major uncontrolled psychiatric disorder or other comorbid cognitive conditions, which the treating HCT clinician believes would prohibit the patients' capacity to provide informed consent and participate in study procedures.
Key Trial Info
Start Date :
January 27 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2030
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06541002
Start Date
January 27 2025
End Date
April 30 2030
Last Update
May 25 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Coral Gables, Florida, United States, 33124
2
Massachusetts General Hospital (MGH)
Boston, Massachusetts, United States, 02114
3
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111